Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0510-2023

Drug recall · April 12, 2023

Montelukast Sodium Oral Granules USP recall

Why: Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Carton NDC 0093-7487-56, Packet NDC 0093-7487-19

Lots / codes

Lot # 3007556A, Exp 5/2023

Quantity
3,772 cartons
Company
Teva Pharmaceuticals USA Inc, Parsippany, NJ
Distribution
USA Nationwide
Initiated
March 27, 2023 · Voluntary: Firm initiated
Classified
April 6, 2023
Reported
April 12, 2023
Ended
August 23, 2023
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Montelukast

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.